Thermo Fisher (TMO) CEO Marc N. Casper Exercises Options, Sells Shares

What Happened
Marc N. Casper, Chairman, CEO and a director of Thermo Fisher Scientific (TMO), reported option exercises and share sales on 2026-08-24. The filing shows an exercise/conversion (derivative) of 275 shares at a strike of $309.63 (cost $85,148, reported as acquired). On the same date he sold 275 shares in open-market transactions for total proceeds of $172,438 (sales executed in multiple tranches at weighted-average prices shown below). The filing also shows 275 shares disposed in a derivative transaction at $0.00 (likely shares surrendered to cover taxes/withholding).

Key Details

• Transaction date: 2026-08-24; Form 4 filed 2026-08-26 (filed timely).
• Option exercise: 275 shares exercised at $309.63 each — total reported cost $85,148. (Footnote F7: option vested in four equal installments on Feb 25 of 2021–2024.)
• Open-market sales: 275 shares sold in multiple transactions for total proceeds $172,438. Breakout (weighted-average prices reported):
  • 101 shares @ $625.41 (sales priced between $625.00–$625.98) (F2)
  • 33 shares @ $626.59 (prices $626.25–$627.21) (F3)
  • 79 shares @ $628.01 (prices $627.43–$628.34) (F4)
  • 62 shares @ $628.74 (prices $628.48–$628.89) (F5)
• Derivative disposal: 275 shares reported disposed at $0.00 (reported as a derivative disposition).
• Plan/footnotes: Transactions were effected pursuant to a Rule 10b5-1 trading plan adopted April 27, 2026 (F1). The filer disclaims beneficial ownership of certain securities as indirectly beneficially owned except for any pecuniary interest (F6).
• Shares owned after the transactions: not stated in the provided data.

Context

• This was a mixed transaction: an option exercise (acquisition) coupled with share disposals. The zero-dollar derivative disposition and the open-market sales are commonly used to cover tax withholding and to monetize exercised option gains; the filing indicates the activity was conducted under a pre-arranged 10b5-1 trading plan.
• For retail investors: purchases are often seen as stronger bullish signals than routine exercises/sales. Here, while options were exercised, an equal number of shares were sold/surrendered, so the filing primarily represents routine insider liquidity rather than a clear buy signal.